University Medical Center of the Johannes Gutenberg University Mainz
Mainz, Rhineland-Palatinate, 55131, Germany
NCT Number: NCT02181049
Due to remarkable advances in childhood cancer therapy the 10-year survival rate increased to over 80% and late sequelae come to the fore. Childhood cancer survivors (CCS) suffer from significant excess in mortality risk associated with treatment-related complications at least for 25 years after the initial cancer diagnosis. In particular, the prevalence of cardiovascular disease seems to be elevated compared to the general population. The CVSS study is a multi-disciplinary cooperation project between the Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI) and the German Childhood Cancer Registry (GCCR), the Preventive Cardiology and Preventive Medicine and the Pediatric Hematology and Oncology all at the University Medical Center of the Johannes Gutenberg University Mainz. The central element is a thorough clinical cardiovascular examination of all patients, which permits detecting subclinical disease. Therapy data will be extracted retrospectively from various sources. The study intends to describe the current situation of a cohort of approximately 1000 CCS in Germany aged 24 to 49 years with respect to cardiovascular health. The role of risk factors (treatment related and classic cardiovascular risk factors), as well as related predisposing genetic factors is investigated. The results will contribute to recommendations to improve follow-up care.
This study is active but is not currently recruiting participants.
Notify Me24 year–49 year
All sexes
Observational
Mainz, Rhineland-Palatinate, 55131, Germany
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 35 years after exposure to childhood cancer therapy
Time frame: up to 35 years after exposure to childhood cancer therapy
Time frame: up to 35 years after exposure to childhood cancer therapy
Time frame: up to 35 years after exposure to childhood cancer therapy
"late" is defined as 5 years or more after diagnosis of cancer
Time frame: up to 35 years after exposure to childhood cancer therapy
CVSS study
Other
Cardiac and Vascular Late Sequelae in Long-term Survivors of Childhood Cancer (CVSS): a Multidisciplinary Clinical, Epidemiological and Genetic Approach
Acronym: CVSS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00339495
Cancer, Death
Rockville, Maryland, United States
View Trial DetailsNCT06383390
Arterial Occlusive Diseases, Arteriosclerosis
Alabaster, Alabama, United States
View Trial DetailsNCT04261088
Assisted Suicide, Behavior
Bethesda, Maryland, United States
View Trial DetailsNCT05861323
Aging, Coma
Boston, Massachusetts, United States
View Trial Details